Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The global hearing therapeutic pipeline: 2021
Beverley Isherwood, Ana Cláudia Gonçalves, Rick Cousins, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 3, pp. 912-922
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss
Winston Tan, Lei Song
Hearing Research (2023) Vol. 434, pp. 108783-108783
Closed Access | Times Cited: 66
Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions
Winston Tan, Srdjan M. Vlajkovic
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16545-16545
Open Access | Times Cited: 40
A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss
Anne GM Schilder, Stephan Wolpert, Shakeel R. Saeed, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Overcoming barriers: a review on innovations in drug delivery to the middle and inner ear
Derek S. Delaney, Lawrence J. Liew, Joey Lye, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Microneedle-mediated intracochlear injection safely achieves higher perilymphatic dexamethasone concentration than intratympanic delivery in guinea pig
François Voruz, Sharon J. Feng, Eugénie Breil, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Using Active Noise Cancellation Technology to Enhance Streaming Audio Listening Benefits for Hearing-Impaired Individuals in Noisy Environments
Hsin-Jui Lee, Chin-Yu Chou, Ying-Hui Lai
IFMBE proceedings (2025), pp. 3-14
Closed Access
Cochlear Implantation Is Associated With Reduced Incidence of Dementia in Severe Hearing Loss
Hee Won Seo, Soorack Ryu, Sang‐Yoon Han, et al.
Ear and Hearing (2025)
Closed Access
Noise-induced hearing disorders: Clinical and investigational tools
Colleen G. Le Prell, Odile Clavier, Jianxin Bao
The Journal of the Acoustical Society of America (2023) Vol. 153, Iss. 1, pp. 711-722
Open Access | Times Cited: 10
Extracellular vesicles for developing targeted hearing loss therapy
Xiaoshu Pan, Yanjun Li, Peixin Huang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 460-478
Closed Access | Times Cited: 3
Intratympanic Gels for Inner Ear Disorders: A Scoping Review of Clinical Trials
Davide Brotto, Marco Greggio
Otolaryngology (2024) Vol. 170, Iss. 6, pp. 1613-1629
Open Access | Times Cited: 3
Ototoxicity: a high risk to auditory function that needs to be monitored in drug development
Marie-Pierre Pasdelou, Lise Byelyayeva, Susanna Malmström, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 3
The audiogram: Detection of pure-tone stimuli in ototoxicity monitoring and assessments of investigational medicines for the inner ear
Colleen G. Le Prell, Carmen C. Brewer, Kathleen C. M. Campbell
The Journal of the Acoustical Society of America (2022) Vol. 152, Iss. 1, pp. 470-490
Open Access | Times Cited: 13
Therapeutics for hearing preservation and improvement of patient outcomes in cochlear implantation—Progress and possibilities
Robert D. Gay, Ya Lang Enke, Jonathon R. Kirk, et al.
Hearing Research (2022) Vol. 426, pp. 108637-108637
Open Access | Times Cited: 13
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy
Victoria A. Sanchez, Paul C. Dinh, Jennessa Rooker, et al.
Journal of Cancer Survivorship (2023) Vol. 17, Iss. 1, pp. 27-39
Open Access | Times Cited: 7
Hearing loss drug discovery and medicinal chemistry: Current status, challenges, and opportunities
Rick Cousins
Progress in medicinal chemistry (2022), pp. 1-91
Closed Access | Times Cited: 12
Novel Nanoencapsulation Technology and its Potential Role in Bile Acid‐Based Targeted Gene Delivery to the Inner Ear
Thomas S. Foster, Michael Lewkowicz, Christina Quintas, et al.
Small (2022) Vol. 19, Iss. 8
Closed Access | Times Cited: 10
A prestin-targeting peptide-guided drug delivery system rearranging concentration gradient in the inner ear: An improved strategy against hearing loss
Xinrui Wang, Zeming Zhou, Chong Yu, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 187, pp. 106490-106490
Open Access | Times Cited: 4
Incidence of cisplatin-induced ototoxicity in adult cancer patients based on audiometric confirmation of patient self-report
François Voruz, Aurélie Vuilleumier, Denis Migliorini, et al.
Frontiers in Audiology and Otology (2023) Vol. 1
Open Access | Times Cited: 4
Speech-in-noise testing: Innovative applications for pediatric patients, underrepresented populations, fitness for duty, clinical trials, and remote services
Victoria A. Sanchez, Michelle Arnold, David R. Moore, et al.
The Journal of the Acoustical Society of America (2022) Vol. 152, Iss. 4, pp. 2336-2356
Open Access | Times Cited: 7
Sheep as a large animal model for hearing research: comparison to common laboratory animals and humans
Po‐Yi Lue, Mark H. Oliver, Michel Neeff, et al.
Laboratory Animal Research (2023) Vol. 39, Iss. 1
Open Access | Times Cited: 2
Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear
Thomas S. Foster, Patrick J. Lim, Corina Mihaela Ionescu, et al.
Therapeutic Delivery (2024) Vol. 15, Iss. 10, pp. 801-818
Closed Access
Molecular and Clinical Characterization of a Cohort of Autosomal Recessive Sensorineural Hearing Loss in Egyptian Patients
Mohammed M. Sayed-Ahmed, Hala T. El‐Bassyouni, Hanan H. Afifi, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 4
Open Access
Das Jahr 2022: Trendwende der Hörsturztherapie?
Olaf Michel
HNO Nachrichten (2023) Vol. 53, Iss. 1, pp. 35-37
Closed Access | Times Cited: 1
Preclinical prospects of investigational agents for hearing loss treatment
Colleen G. Le Prell
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 685-692
Closed Access | Times Cited: 1
Trendwende der Hörsturztherapie in Sicht?
Olaf Michel
HNO Nachrichten (2022) Vol. 52, Iss. 1, pp. 48-53
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top